Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4)

1. Hézode, C.
2. Alric, L.
3. Brown, A.
4. Hassanein, T.
5. Rizzetto, M.
6. Buti, M.
7. Bourlière, M.
8. Thabut, D.
9. Molina, E.
10. Rustgi, V.
11. Samuel, D.
12. McPhee, F.
13. Liu, Z.
14. Yin, P.D.
15. Hughes, E.
16. Treitel, M.